Abstract
[This corrects the article DOI: 10.3892/ol.2019.10017.].
Highlights
To the publication of this article, the Editor of Oncology Letters received notification that the use of the abbreviation “ISET” in this paper represented an infringement of a trademark owned by the company “Rarecells”, who are the exclusive licensee of several patents covering the “ISET” system and of the ISET® device
Upon drawing this matter to the authors' attention, they noted that their use of the term “ISET” as an abbreviation was solely to represent the technique of “isolation by size of epithelial tumor cells”
The authors regret any inconvenience caused in this regard. Note that these changes regarding the removal of the abbreviation “ISET” from this article do not affect any of the results or conclusions reported in this study
Summary
To the publication of this article, the Editor of Oncology Letters received notification that the use of the abbreviation “ISET” in this paper represented an infringement of a trademark owned by the company “Rarecells”, who are the exclusive licensee of several patents covering the “ISET” system and of the ISET® device. Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
